1. Home
  2. DYN vs NSP Comparison

DYN vs NSP Comparison

Compare DYN & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • NSP
  • Stock Information
  • Founded
  • DYN 1984
  • NSP 1986
  • Country
  • DYN United States
  • NSP United States
  • Employees
  • DYN N/A
  • NSP N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • NSP Professional Services
  • Sector
  • DYN Health Care
  • NSP Consumer Discretionary
  • Exchange
  • DYN Nasdaq
  • NSP Nasdaq
  • Market Cap
  • DYN 1.9B
  • NSP 2.0B
  • IPO Year
  • DYN 2020
  • NSP 1997
  • Fundamental
  • Price
  • DYN $13.15
  • NSP $51.36
  • Analyst Decision
  • DYN Strong Buy
  • NSP Hold
  • Analyst Count
  • DYN 14
  • NSP 4
  • Target Price
  • DYN $34.93
  • NSP $58.33
  • AVG Volume (30 Days)
  • DYN 2.2M
  • NSP 506.3K
  • Earning Date
  • DYN 11-11-2025
  • NSP 10-30-2025
  • Dividend Yield
  • DYN N/A
  • NSP 4.59%
  • EPS Growth
  • DYN N/A
  • NSP N/A
  • EPS
  • DYN N/A
  • NSP 1.05
  • Revenue
  • DYN N/A
  • NSP $6,695,000,000.00
  • Revenue This Year
  • DYN N/A
  • NSP $5.06
  • Revenue Next Year
  • DYN N/A
  • NSP $5.35
  • P/E Ratio
  • DYN N/A
  • NSP $49.64
  • Revenue Growth
  • DYN N/A
  • NSP 2.40
  • 52 Week Low
  • DYN $6.36
  • NSP $44.14
  • 52 Week High
  • DYN $37.08
  • NSP $95.98
  • Technical
  • Relative Strength Index (RSI)
  • DYN 56.80
  • NSP 42.35
  • Support Level
  • DYN $12.65
  • NSP $50.75
  • Resistance Level
  • DYN $13.68
  • NSP $54.25
  • Average True Range (ATR)
  • DYN 0.67
  • NSP 1.95
  • MACD
  • DYN -0.16
  • NSP -0.19
  • Stochastic Oscillator
  • DYN 30.72
  • NSP 9.43

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: